Ning Chen

Title: Ning Chen: Innovator in Gene Modulation

Introduction

Ning Chen is a prominent inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of gene modulation, particularly focusing on heat shock protein 47 (HSP47). With a total of 3 patents to his name, Chen's work has the potential to impact various medical conditions.

Latest Patents

One of Ning Chen's latest patents involves the modulation of HSP47 expression. This patent provides compositions, methods, and kits for modulating the expression of target genes, specifically HSP47. The compositions may include nucleic acid molecules such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), or short hairpin RNA (shRNA). These innovations aim to modulate the gene encoding human HSP47, which is crucial in treating conditions associated with HSP47, including liver fibrosis, pulmonary fibrosis, peritoneal fibrosis, and kidney fibrosis.

Career Highlights

Ning Chen is currently associated with Nitto Denko Corporation, where he continues to advance his research and innovations. His work is characterized by a strong focus on therapeutic applications of gene modulation.

Collaborations

Some of his notable coworkers include Xiaomei Jin and Lei Yu, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Ning Chen's innovative work in gene modulation, particularly concerning HSP47, showcases his commitment to advancing medical science. His contributions have the potential to lead to significant advancements in the treatment of various fibrotic conditions.